Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...

Revenues: Revenues for the third quarter of 2024 were approximately $2.3 million compared to $6.2 million for the third quarter of 2023.

Capricor Therapeutics Reports Third Quarter 2024 Financial

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update ; REVENUE. Revenue ; Revenue, $, 2,261,642 ; TOTAL ...

Capricor Therapeutics Third Quarter 2024 Earnings - Yahoo Finance

Capricor Therapeutics ( NASDAQ:CAPR ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.26m (down 63% from...

Capricor Therapeutics to Present Third Quarter 2024 Financial ...

Company to Host Conference Call, November 13, 2024 at 4:30 p.m. ET ; Title: Capricor Therapeutics Third Quarter 2024 Financial Results and Recent ...

Capricor Therapeutics Third Quarter 2024 Financial Results and ...

Capricor Therapeutics Third Quarter 2024 Financial Results and Corporate Update Conference Call ... Participants can use guest dial-in numbers ...

FORM 8-K - Capricor Therapeutics

Press Release, titled “Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update”, dated November 13, ...

Capricor Therapeutics to Present Third Quarter 2024 Financial ...

Company to Host Conference Call, November 13, 2024 at 4:30 p.m. ETSAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics ...

Capricor Therapeutics, Inc. (CAPR)

Latest News · Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to Present Exosome Platform ...

Financial Results - Capricor Therapeutics

Financial Info. Overview · Financial Results. 2024. Q2 2024. Quarter Ended Jun 30, 2024. Earnings Release · PDF HTML · Earnings Webcast.

Capricor Therapeutics Sets Q3 Earnings Call for Nov 13 - Stock Titan

Capricor Therapeutics will release its Q3 2024 financial results after market close on Wednesday, November 13, 2024. What time is Capricor ...

Investors :: Capricor Therapeutics, Inc. (CAPR)

Latest News · Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to Present Exosome Platform ...

Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...

13, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based ...

Financial Information :: Capricor Therapeutics, Inc. (CAPR)

Financial Info. Overview · Financial Results. Latest Financial Results. Q3 2024. Quarter Ended Sep 30, 2024. Earnings Release · PDF HTML · Earnings Webcast.

Capricor Therapeutics Q3 2024 Financial Results and Corporate ...

The company's cash position improved significantly, with cash, cash equivalents, and marketable securities totaling approximately $85.0 million ...

Capricor Therapeutics to Present Third Quarter 2024 Financial ...

Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13 ; October 21st, 5:35 am, +629%, $35.00 ; May 17th ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to Present Exosome Platform Updates at ...

Intensity Therapeutics Reports Third Quarter 2024 Financial Results ...

Overall, net loss was $3.5 million for the three months ended September 30, 2024, compared to a net loss of $2.3 million for the three months ...

Capricor Therapeutics reports Q3 EPS (38c), consensus (36c)

Capricor Therapeutics NewsMORE · Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor ...

Buy Capricor Therapeutics (CAPR) Stock - Public Investing

Capricor Therapeutics (CAPR) reported Q3 2024 earnings per share (EPS) of -$0.38, missing estimates of -$0.36 by 5.56%. In the same quarter last year, Capricor ...

Capricor Therapeutics, Inc. Reports Earnings Results for the Third ...

Capricor Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, ...